Tuesday, January 02, 2018 10:15 PM ET
Significant Insider Sales Reported in Shares of Atara Biotherapeutics (ATRA) Extending the Trend of Last Quarter
Two insiders — John McGrath, Officer, and Isaac E Ciechanover, Director and Officer — sold 54,200 shares of Atara Biotherapeutics having a market value of approximately $1,045,958, today, as revealed in form 4 documents filed with the SEC. There have been 2 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the sale of 28,000 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 82,200 shares and have averaged 20,550 shares per transaction over this time period.
The number of insider buy/sell trades at Atara Biotherapeutics is above that of the 279 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 309 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Atara Biotherapeutics insiders is lower than its peers. Within the peer group there were 42,403,206 shares purchased and 35,260,149 shares sold with company insiders acquiring 35,715 shares on average over this time period.
The data obtained in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Today’s Insider Activity
* John McGrath, Officer, sold 32,000 shares
* Isaac E Ciechanover, Director and Officer, sold 22,200 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.